Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
Department of Community Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Cochrane Database Syst Rev. 2021 Jan 18;1(1):CD011302. doi: 10.1002/14651858.CD011302.pub3.
Anaemia is a condition where the number of red blood cells (and consequently their oxygen-carrying capacity) is insufficient to meet the body's physiological needs. Fortification of wheat flour is deemed a useful strategy to reduce anaemia in populations.
To determine the benefits and harms of wheat flour fortification with iron alone or with other vitamins and minerals on anaemia, iron status and health-related outcomes in populations over two years of age.
We searched CENTRAL, MEDLINE, Embase, CINAHL, 21 other databases and two trials registers up to 21 July 2020, together with contacting key organisations to identify additional studies.
We included cluster- or individually-randomised controlled trials (RCTs) carried out among the general population from any country, aged two years and above. The interventions were fortification of wheat flour with iron alone or in combination with other micronutrients. We included trials comparing any type of food item prepared from flour fortified with iron of any variety of wheat DATA COLLECTION AND ANALYSIS: Two review authors independently screened the search results and assessed the eligibility of studies for inclusion, extracted data from included studies and assessed risks of bias. We followed Cochrane methods in this review.
Our search identified 3538 records, after removing duplicates. We included 10 trials, involving 3319 participants, carried out in Bangladesh, Brazil, India, Kuwait, Philippines, South Africa and Sri Lanka. We identified two ongoing studies and one study is awaiting classification. The duration of interventions varied from 3 to 24 months. One study was carried out among adult women and one trial among both children and nonpregnant women. Most of the included trials were assessed as low or unclear risk of bias for key elements of selection, performance or reporting bias. Three trials used 41 mg to 60 mg iron/kg flour, three trials used less than 40 mg iron/kg and three trials used more than 60 mg iron/kg flour. One trial used various iron levels based on type of iron used: 80 mg/kg for electrolytic and reduced iron and 40 mg/kg for ferrous fumarate. All included studies contributed data for the meta-analyses. Iron-fortified wheat flour with or without other micronutrients added versus wheat flour (no added iron) with the same other micronutrients added Iron-fortified wheat flour with or without other micronutrients added versus wheat flour (no added iron) with the same other micronutrients added may reduce by 27% the risk of anaemia in populations (risk ratio (RR) 0.73, 95% confidence interval (CI) 0.55 to 0.97; 5 studies, 2315 participants; low-certainty evidence). It is uncertain whether iron-fortified wheat flour with or without other micronutrients reduces iron deficiency (RR 0.46, 95% CI 0.20 to 1.04; 3 studies, 748 participants; very low-certainty evidence) or increases haemoglobin concentrations (in g/L) (mean difference MD 2.75, 95% CI 0.71 to 4.80; 8 studies, 2831 participants; very low-certainty evidence). No trials reported data on adverse effects in children (including constipation, nausea, vomiting, heartburn or diarrhoea), except for risk of infection or inflammation at the individual level. The intervention probably makes little or no difference to the risk of Infection or inflammation at individual level as measured by C-reactive protein (CRP) (mean difference (MD) 0.04, 95% CI -0.02 to 0.11; 2 studies, 558 participants; moderate-certainty evidence). Iron-fortified wheat flour with other micronutrients added versus unfortified wheat flour (nil micronutrients added) It is unclear whether wheat flour fortified with iron, in combination with other micronutrients decreases anaemia (RR 0.77, 95% CI 0.41 to 1.46; 2 studies, 317 participants; very low-certainty evidence). The intervention probably reduces the risk of iron deficiency (RR 0.73, 95% CI 0.54 to 0.99; 3 studies, 382 participants; moderate-certainty evidence) and it is unclear whether it increases average haemoglobin concentrations (MD 2.53, 95% CI -0.39 to 5.45; 4 studies, 532 participants; very low-certainty evidence). No trials reported data on adverse effects in children. Nine out of 10 trials reported sources of funding, with most having multiple sources. Funding source does not appear to have distorted the results in any of the assessed trials.
AUTHORS' CONCLUSIONS: Fortification of wheat flour with iron (in comparison to unfortified flour, or where both groups received the same other micronutrients) may reduce anaemia in the general population above two years of age, but its effects on other outcomes are uncertain. Iron-fortified wheat flour in combination with other micronutrients, in comparison with unfortified flour, probably reduces iron deficiency, but its effects on other outcomes are uncertain. None of the included trials reported data on adverse side effects except for risk of infection or inflammation at the individual level. The effects of this intervention on other health outcomes are unclear. Future studies at low risk of bias should aim to measure all important outcomes, and to further investigate which variants of fortification, including the role of other micronutrients as well as types of iron fortification, are more effective, and for whom.
贫血是指红细胞数量(及其携氧能力)不足以满足身体生理需求的一种状况。小麦粉强化被认为是减少人群贫血的一种有用策略。
确定单独用铁或与其他维生素和矿物质强化小麦粉对 2 岁及以上人群贫血、铁状态和健康相关结局的益处和危害。
我们检索了 CENTRAL、MEDLINE、Embase、CINAHL、21 个其他数据库和两个试验注册库,截至 2020 年 7 月 21 日,并联系了关键组织以确定其他研究。
我们纳入了在任何国家、年龄在 2 岁及以上的普通人群中进行的群组或个体随机对照试验(RCT)。干预措施是单独用铁或与其他微量营养素一起强化小麦粉。我们纳入了比较任何类型的用任何品种的小麦制成的面粉制作的食物的试验。
两名综述作者独立筛选检索结果,评估研究纳入的资格,从纳入的研究中提取数据,并评估偏倚风险。我们在本综述中遵循了 Cochrane 方法。
我们的搜索共确定了 3538 条记录,去除重复项后。我们纳入了 10 项试验,涉及 3319 名参与者,在孟加拉国、巴西、印度、科威特、菲律宾、南非和斯里兰卡进行。我们发现两项正在进行的研究和一项研究正在等待分类。干预的持续时间从 3 个月到 24 个月不等。一项研究针对成年女性,一项试验针对儿童和非孕妇。大多数纳入的试验在选择、实施或报告偏倚的关键要素方面被评估为低或不确定偏倚风险。三项试验使用了 41 毫克至 60 毫克铁/千克面粉,三项试验使用了少于 40 毫克铁/千克面粉,三项试验使用了超过 60 毫克铁/千克面粉。一项试验使用了基于所用铁类型的不同铁水平:电解铁和还原铁为 80 毫克/千克,富马酸亚铁为 40 毫克/千克。所有纳入的研究都为荟萃分析提供了数据。
用或不用其他微量营养素强化的小麦粉与用相同其他微量营养素强化的小麦粉(无添加铁)相比
用或不用其他微量营养素强化的小麦粉与用相同其他微量营养素强化的小麦粉(无添加铁)相比,可能会降低人群贫血的风险 27%(风险比(RR)0.73,95%置信区间(CI)0.55 至 0.97;5 项研究,2315 名参与者;低质量证据)。用或不用其他微量营养素强化的小麦粉是否能降低缺铁(RR 0.46,95%CI 0.20 至 1.04;3 项研究,748 名参与者;极低质量证据)或增加血红蛋白浓度(g/L)(均值差 MD 2.75,95%CI 0.71 至 4.80;8 项研究,2831 名参与者;极低质量证据),尚不确定。除了个体层面的感染或炎症风险外,没有试验报告儿童(包括便秘、恶心、呕吐、胃灼热或腹泻)的不良影响数据。干预措施对个体层面的感染或炎症风险(用 C 反应蛋白(CRP)衡量)可能没有影响或影响很小(MD 0.04,95%CI -0.02 至 0.11;2 项研究,558 名参与者;中等质量证据)。
用其他微量营养素强化的小麦粉与未强化的小麦粉(无添加微量营养素)相比
用其他微量营养素强化的小麦粉与未强化的小麦粉(无添加微量营养素)相比,尚不确定是否会降低缺铁性贫血的风险(RR 0.77,95%CI 0.41 至 1.46;2 项研究,317 名参与者;极低质量证据)。该干预措施可能降低缺铁(RR 0.73,95%CI 0.54 至 0.99;3 项研究,382 名参与者;中等质量证据)的风险,但尚不确定它是否增加平均血红蛋白浓度(MD 2.53,95%CI -0.39 至 5.45;4 项研究,532 名参与者;极低质量证据)。没有试验报告儿童的不良影响数据。10 项试验中有 9 项报告了资金来源,其中大多数有多个来源。资金来源似乎没有在任何评估的试验中扭曲结果。
与未强化面粉或两组均接受相同其他微量营养素相比,用铁强化小麦粉(与未强化面粉或两组均接受相同其他微量营养素相比)可能会降低 2 岁及以上人群的贫血风险,但对其他结局的影响尚不确定。与未强化面粉相比,用铁与其他微量营养素强化的小麦粉可能会降低缺铁性贫血的风险,但对其他结局的影响尚不确定。除了个体层面的感染或炎症风险外,没有试验报告儿童的不良影响数据。该干预措施对其他健康结局的影响尚不清楚。未来的研究应在低偏倚风险下进行,目的是测量所有重要的结局,并进一步研究哪种强化变体更有效,包括其他微量营养素的作用以及不同铁强化变体的作用,以及对谁更有效。